Log in
Enquire now
Neukio Biotherapeutics

Neukio Biotherapeutics

Neukio Biotherapeutics focuses on development of next generation allogenic cell therapies via the iPSC-CAR-NK axis.

OverviewStructured DataIssuesContributors

Contents

neukio.com/en
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Immunotherapy
Immunotherapy
‌
Genome editing
Genomics
Genomics
Cell therapy
Cell therapy
‌
Allogeneic cell therapy
Biotechnology
Biotechnology
Location
Shanghai
Shanghai
CEO
‌
Richard Wang
Email Address
Technologies Used
CRISPR
CRISPR
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Neukio Biotherapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.